BCM
PRME icon

Bridgeway Capital Management’s Prime Medicine PRME Stock Holding History

Bridgeway Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$469K Hold
134,800
– – 0.01% 833
2025
Q4 		$468K Sell
134,800
-30,000
-18% -$133K 0.01% 835
2025
Q3 		$913K Sell
164,800
-50,000
-23% -$203K 0.02% 713
2025
Q2 		$531K Buy
+214,800
New +$331K 0.01% 769

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Bridgeway Capital Management's PRME Position: Q1 2026 in Review

Bridgeway Capital Management held its Prime Medicine (PRME) position steady in Q1 2026 at 134,800 shares worth $469K. The position accounts for 0.01% of the portfolio, ranked #833.

Bridgeway Capital Management first reported a position in PRME in Q2 2025 and has held it in 4 quarters since. The position peaked at $913K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Bridgeway Capital Management held 134,800 shares of Prime Medicine worth $469K as of Q1 2026.
  • Bridgeway Capital Management left its Prime Medicine share count unchanged in Q1 2026.
  • Prime Medicine made up 0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #833 holding.
  • Bridgeway Capital Management first reported a position in Prime Medicine in Q2 2025 and has held it in 4 quarters since.
  • Bridgeway Capital Management's Prime Medicine position peaked at $913K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.